
FDA/CDER Novel Drug Approvals 2023
In 2023, the FDA's Center for Drug Evaluation and Research (CDER) approved several novel drugs, advancing treatments for various conditions. These approvals highlight innovation in fields like oncology, neurology, and infectious diseases. Each drug undergoes rigorous testing to ensure safety and efficacy, contributing to improved patient care and the expansion of therapeutic options for complex diseases.